Synopsis
Synopsis
0
VMF
0
Europe
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4h-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-
2. Dihydrate, Ondansetron Monohydrochloride
3. Gr 38032f
4. Gr-38032f
5. Gr38032f
6. Hydrochloride, Ondansetron
7. Monohydrochloride Dihydrate, Ondansetron
8. Monohydrochloride, Ondansetron
9. Odt, Zofran
10. Ondansetron
11. Ondansetron Monohydrochloride
12. Ondansetron Monohydrochloride Dihydrate
13. Ondansetron, (+,-)-isomer
14. Ondansetron, (r)-isomer
15. Ondansetron, (s)-isomer
16. Sn 307
17. Sn-307
18. Sn307
19. Zofran
20. Zofran Odt
1. Ondansetron Hcl
2. 99614-01-4
3. Zofran
4. Ondemet
5. Emeset
6. Ondansetron (hydrochloride)
7. Zofran Odt
8. Nsc 665799
9. Ondansetronhydrochloride
10. 2999f27mad
11. Nsc-665799
12. C18h20cln3o
13. 4h-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-, Monohydrochloride
14. Emetron
15. 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one Hydrochloride
16. 9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4h-carbazol-4-one Hydrochloride
17. 9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-2,3-dihydro-1h-carbazol-4(9h)-one Hydrochloride
18. Smr000469179
19. Gr 38032
20. Unii-2999f27mad
21. Sr-01000763250
22. Zofran Preservative Free
23. Zofran And Dextrose In Plastic Container
24. Cpd000469179
25. Ondansetron Hydrochloride Preservative Free
26. 9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one Monohydrochloride
27. Schembl41455
28. Mls001304076
29. Mls001401397
30. Mls002222312
31. Regid_for_cid_68647
32. Gr 38032 Hcl
33. Ondansetron Hydrochloride, 98%
34. Chembl1201111
35. Ondansetron Hydrochloride- Bio-x
36. Ondansetron Hydrochloride And Dextrose In Plastic Container
37. Dtxsid701027913
38. Hms1571c18
39. Ondansetron Hydrochloride (zofran)
40. Hy-b0002
41. Ondansetron Hydrochloride And Sodium Chloride In Plastic Container
42. Mfcd00764297
43. Nsc665799
44. S1390
45. Ondansetron Hydrochloride [mi]
46. Akos015889292
47. Ab07046
48. Ccg-100852
49. Ccg-221058
50. Cs-1715
51. Gs-3597
52. H39o049
53. Nc00102
54. Ac-12464
55. Bo164177
56. Ondansetron Hydrochloride [who-dd]
57. Ondansetron Hydrochloride Anhydrous
58. O0407
59. Sw100810-5
60. Vu0424014-2
61. C90628
62. (+/-)-ondansetron Hydrochloride Anhydrous
63. A800774
64. Ondansetron Hydrochloride Anhydrous, (+/-)-
65. Q-201515
66. Sr-01000763250-5
67. Q27254405
68. 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1h-carbazol-4-one;hydrochloride
69. 1,2,3,4-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-9h-carbazol-4-one Hydrochloride
70. 4h-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-, Hydrochloride (1:1)
71. 9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1h-carbazol-4-one Hydrochloride
Molecular Weight | 329.8 g/mol |
---|---|
Molecular Formula | C18H20ClN3O |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Exact Mass | 329.1294900 g/mol |
Monoisotopic Mass | 329.1294900 g/mol |
Topological Polar Surface Area | 39.8 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 440 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Ondansetron hydrochloride |
Drug Label | The active ingredient in ZOFRAN Tablets and ZOFRAN Oral Solution is ondansetron hydrochloride (HCl) as the dihydrate, the racemic form of ondansetron and a selective blocking agent of the serotonin 5-HT3 receptor type. Chemically it is (1, 2, 3, 9-te... |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Tablet; Injectable; Solution |
Route | oral; Injection; Oral |
Strength | eq 4mg base; eq 2mg base/ml; eq 4mg base/5ml; eq 16mg; eq 16mg base; 16mg; eq 24mg base; eq 8mg base |
Market Status | Tentative Approval; Prescription |
Company | Amneal Pharms; Wockhardt; Silarx; Bedford; Hospira; Gland Pharma; Sun Pharm Inds (in); Teva; Apotex; Hikma Farmaceutica; Aurobindo Pharma; Natco Pharma; Taro; Sandoz; Par Pharm; Roxane; Glenmark Generics; Emcure Pharms; Fresenius Kabi Usa; Ipca Labs; Hikm |
2 of 6 | |
---|---|
Drug Name | Ondansetron hydrochloride preservative free |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 2mg base/ml |
Market Status | Prescription |
Company | Wockhardt; Hospira; Teva; Hikma Farmaceutica; Aurobindo Pharma; Sun Pharm Inds; Sandoz; Emcure Pharms; Fresenius Kabi Usa; Hikma Maple; Claris Lifesciences; Taro Pharms Ireland; Luitpold; Bedford Labs; Agila Speclts; Bd Rx |
3 of 6 | |
---|---|
Drug Name | Zofran preservative free |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 2mg base/ml |
Market Status | Prescription |
Company | Glaxosmithkline |
4 of 6 | |
---|---|
Drug Name | Ondansetron hydrochloride |
Drug Label | The active ingredient in ZOFRAN Tablets and ZOFRAN Oral Solution is ondansetron hydrochloride (HCl) as the dihydrate, the racemic form of ondansetron and a selective blocking agent of the serotonin 5-HT3 receptor type. Chemically it is (1, 2, 3, 9-te... |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Tablet; Injectable; Solution |
Route | oral; Injection; Oral |
Strength | eq 4mg base; eq 2mg base/ml; eq 4mg base/5ml; eq 16mg; eq 16mg base; 16mg; eq 24mg base; eq 8mg base |
Market Status | Tentative Approval; Prescription |
Company | Amneal Pharms; Wockhardt; Silarx; Bedford; Hospira; Gland Pharma; Sun Pharm Inds (in); Teva; Apotex; Hikma Farmaceutica; Aurobindo Pharma; Natco Pharma; Taro; Sandoz; Par Pharm; Roxane; Glenmark Generics; Emcure Pharms; Fresenius Kabi Usa; Ipca Labs; Hikm |
5 of 6 | |
---|---|
Drug Name | Ondansetron hydrochloride preservative free |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 2mg base/ml |
Market Status | Prescription |
Company | Wockhardt; Hospira; Teva; Hikma Farmaceutica; Aurobindo Pharma; Sun Pharm Inds; Sandoz; Emcure Pharms; Fresenius Kabi Usa; Hikma Maple; Claris Lifesciences; Taro Pharms Ireland; Luitpold; Bedford Labs; Agila Speclts; Bd Rx |
6 of 6 | |
---|---|
Drug Name | Zofran preservative free |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 2mg base/ml |
Market Status | Prescription |
Company | Glaxosmithkline |
Treatment of alcohol use disorder
Serotonin 5-HT3 Receptor Antagonists
Drugs that bind to but do not activate SEROTONIN 5-HT3 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT3 RECEPTOR AGONISTS. (See all compounds classified as Serotonin 5-HT3 Receptor Antagonists.)
Antipruritics
Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16317
Submission : 2002-12-13
Status : Active
Type : II
Certificate Number : R1-CEP 2005-056 - Rev 00
Issue Date : 2012-05-24
Type : Chemical
Substance Number : 2016
Status : Valid
NDC Package Code : 64567-0005
Start Marketing Date : 2009-08-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-09-23
Pay. Date : 2015-09-09
DMF Number : 15436
Submission : 2001-05-15
Status : Active
Type : II
Certificate Number : R1-CEP 2005-071 - Rev 06
Issue Date : 2023-05-23
Type : Chemical
Substance Number : 2016
Status : Valid
Registration Number : 302MF10019
Registrant's Address : 8-2-337, Road No. 3,Banjara Hills,Hyderabad 500 034,TELANGANA,INDIA
Initial Date of Registration : 2020-01-31
Latest Date of Registration :
Date of Issue : 2022-05-27
Valid Till : 2025-06-04
Written Confirmation Number : WC-0043
Address of the Firm :
NDC Package Code : 55111-017
Start Marketing Date : 2010-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Sangjin Corporation
Registration Date : 2021-06-22
Registration Number : 20210426-47-B-440-20(1)
Manufacturer Name : Dr. Reddy's Laboratories Ltd.
Manufacturer Address : Peddadevulapally Village, Tripuraram Mandal, Nalgonda District - 508 207, Telangana State, India
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15642
Submission : 2001-10-01
Status : Active
Type : II
Registration Number : 307MF10012
Registrant's Address : 13 Pallagi u(´)t, Debrecen, 4042-Hungary
Initial Date of Registration : 2025-01-09
Latest Date of Registration :
Available Reg Filing : ASMF |
Delivering Quality APIs, Drug Intermediates, and Specialty Chemicals to Over 50 Countries Across the Globe.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Registration Number : 221MF10130
Registrant's Address : 8-2-337, Road No. 3,Banjara Hills,Hyderabad 500 034,TELANGANA,INDIA
Initial Date of Registration : 2009-06-30
Latest Date of Registration :
Date of Issue : 2022-05-27
Valid Till : 2025-06-04
Written Confirmation Number : WC-0043
Address of the Firm :
Registrant Name : Samil Pharmaceutical Co., Ltd.
Registration Date : 2021-04-26
Registration Number : 20210426-47-B-440-20
Manufacturer Name : Dr. Reddy's Laboratories Ltd.
Manufacturer Address : Chemical Technical Operations - Unit V Peddadevulapally Village, Tripuraram Mandal, Nalgonda District Telangana State, 508 207, India
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16317
Submission : 2002-12-13
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2015-09-23
Pay. Date : 2015-09-09
DMF Number : 15436
Submission : 2001-05-15
Status : Active
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17053
Submission : 2003-12-22
Status : Inactive
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15642
Submission : 2001-10-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16786
Submission : 2003-09-04
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-10-23
Pay. Date : 2018-09-13
DMF Number : 15752
Submission : 2001-12-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15783
Submission : 2001-12-18
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15724
Submission : 2001-11-15
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2021-08-17
Pay. Date : 2021-08-12
DMF Number : 16710
Submission : 2003-07-15
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-02-25
Pay. Date : 2020-02-20
DMF Number : 15990
Submission : 2002-05-27
Status : Active
Type : II
Ondansetron Hydrochloride Dihydrate
Certificate Number : R1-CEP 2005-056 - Rev 00
Status : Valid
Issue Date : 2012-05-24
Type : Chemical
Substance Number : 2016
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Ondansetron Hydrochloride Dihydrate
Certificate Number : R1-CEP 2005-071 - Rev 06
Status : Valid
Issue Date : 2023-05-23
Type : Chemical
Substance Number : 2016
Ondansetron Hydrochloride Dihydrate
Certificate Number : R1-CEP 2004-209 - Rev 03
Status : Valid
Issue Date : 2020-03-04
Type : Chemical
Substance Number : 2016
Ondansetron Hydrochloride Dihydrate
Certificate Number : R1-CEP 2003-130 - Rev 01
Status : Valid
Issue Date : 2011-12-12
Type : Chemical
Substance Number : 2016
Ondansetron Hydrochloride Dihydrate
Certificate Number : R1-CEP 2003-053 - Rev 01
Status : Valid
Issue Date : 2011-08-22
Type : Chemical
Substance Number : 2016
Ondansetron Hydrochloride Dihydrate
Certificate Number : R0-CEP 2017-185 - Rev 00
Status : Expired
Issue Date : 2018-08-17
Type : Chemical
Substance Number : 2016
Ondansetron Hydrochloride Dihydrate
Certificate Number : R1-CEP 2007-237 - Rev 02
Status : Valid
Issue Date : 2019-09-18
Type : Chemical
Substance Number : 2016
Ondansetron Hydrochloride Dihydrate
Certificate Number : R1-CEP 2009-319 - Rev 04
Status : Valid
Issue Date : 2019-09-16
Type : Chemical
Substance Number : 2016
Ondansetron Hydrochloride Dihydrate
Certificate Number : R0-CEP 2019-252 - Rev 00
Status : Valid
Issue Date : 2021-12-06
Type : Chemical
Substance Number : 2016
Ondansetron Hydrochloride Dihydrate
Certificate Number : R0-CEP 2009-191 - Rev 02
Status : Expired
Issue Date : 2014-03-31
Type : Chemical
Substance Number : 2016
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Ondansetron hydrochloride hydrate
Registration Number : 302MF10019
Registrant's Address : 8-2-337, Road No. 3,Banjara Hills,Hyderabad 500 034,TELANGANA,INDIA
Initial Date of Registration : 2020-01-31
Latest Date of Registration : 2020-01-31
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Ondansetron hydrochloride hydrate
Registration Number : 221MF10130
Registrant's Address : 8-2-337, Road No. 3,Banjara Hills,Hyderabad 500 034,TELANGANA,INDIA
Initial Date of Registration : 2009-06-30
Latest Date of Registration : 2016-02-18
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Registration Number : 307MF10012
Registrant's Address : 13 Pallagi u(´)t, Debrecen, 4042-Hungary
Initial Date of Registration : 2025-01-09
Latest Date of Registration : 2025-01-09
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Ondansetron hydrochloride (Teva)
Registration Number : 219MF10022
Registrant's Address : 13 Pallagi u(´)t, Debrecen, 4042-Hungary
Initial Date of Registration : 2007-01-22
Latest Date of Registration : 2017-05-16
Ondansetron hydrochloride hydrate (for manufacturing purposes only)
Registration Number : 306MF10103
Registrant's Address : Sarkhej-Dholka Road, Bhat, Ahmedabad-382 210, Gujarat, INDIA
Initial Date of Registration : 2024-07-17
Latest Date of Registration : 2024-07-17
Registration Number : 219MF10374
Registrant's Address : 1205 11th Street, Charles City, Iowa, U.S. S. A.
Initial Date of Registration : 2007-12-19
Latest Date of Registration : 2007-12-19
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-05-27
Valid Till : 2025-06-04
Written Confirmation Number : WC-0043
Address of the Firm : Chemical Technical Operations ? Unit V, Peddadevulapally Village, Tripuraram Man...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-05-27
Valid Till : 2025-06-04
Written Confirmation Number : WC-0043
Address of the Firm : Chemical Technical Operations ? Unit V, Peddadevulapally Village, Tripuraram Man...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Ondansetron Hydrochloride Dihyrate Ph.Eur
Date of Issue : 2022-05-27
Valid Till : 2025-06-04
Written Confirmation Number : WC-0043
Address of the Firm : Chemical Technical Operations ? Unit V, Peddadevulapally Village, Tripuraram Man...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-05-27
Valid Till : 2025-06-04
Written Confirmation Number : WC-0043
Address of the Firm : Chemical Technical Operations ? Unit V, Peddadevulapally Village, Tripuraram Man...
Ondansetron Hydrochloride EP/USP
Date of Issue : 2022-04-04
Valid Till : 2025-01-13
Written Confirmation Number : WC-0331A2
Address of the Firm : Plot No. 38, Rafaleshwar, GIDC, N. H. No 8/A, At & post Jambudia ? 363 642 Tal: ...
Date of Issue : 2022-08-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0168
Address of the Firm : Plot No. 24/2, & 25, Phase -IV, GIDC Industrial Zone, At & Post - Panoli, Dist.-...
Ondansetron Hydrochloride USP/EP
Date of Issue : 2022-10-17
Valid Till : 2025-08-08
Written Confirmation Number : WC-0382
Address of the Firm : Survey No 353, Domadugu (V), Gummadidala (M), Sangareddy District, Telangana (St...
About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse the...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
About the Company : Emay Pharmaceuticals Pvt Ltd functions as the merchant export division of M/s. Bhavna Laboratories Pvt Ltd. As a GMP-approved API manufacturing company, we boast over three decades...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...
Delivering Quality APIs, Drug Intermediates, and Specialty Chemicals to Over 50 Countries Across the Globe.
About the Company : Zeal MediPharma is a globally recognized Star One Export House, serving customers in over 50 countries for more than two decades. We specialize in sourcing and exporting high-quali...
About the Company : Venkar Chemicals Pvt. Ltd. is a WHO-GMP, ISO 9001:2008, and ISO 14000:2004 certified company and a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediate...
About the Company : Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Mission: Cipla’s mission i...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
43
PharmaCompass offers a list of Ondansetron Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ondansetron Hydrochloride manufacturer or Ondansetron Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ondansetron Hydrochloride manufacturer or Ondansetron Hydrochloride supplier.
PharmaCompass also assists you with knowing the Ondansetron Hydrochloride API Price utilized in the formulation of products. Ondansetron Hydrochloride API Price is not always fixed or binding as the Ondansetron Hydrochloride Price is obtained through a variety of data sources. The Ondansetron Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Emeset manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Emeset, including repackagers and relabelers. The FDA regulates Emeset manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Emeset API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Emeset manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Emeset supplier is an individual or a company that provides Emeset active pharmaceutical ingredient (API) or Emeset finished formulations upon request. The Emeset suppliers may include Emeset API manufacturers, exporters, distributors and traders.
click here to find a list of Emeset suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Emeset DMF (Drug Master File) is a document detailing the whole manufacturing process of Emeset active pharmaceutical ingredient (API) in detail. Different forms of Emeset DMFs exist exist since differing nations have different regulations, such as Emeset USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Emeset DMF submitted to regulatory agencies in the US is known as a USDMF. Emeset USDMF includes data on Emeset's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Emeset USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Emeset suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Emeset Drug Master File in Japan (Emeset JDMF) empowers Emeset API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Emeset JDMF during the approval evaluation for pharmaceutical products. At the time of Emeset JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Emeset suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Emeset Drug Master File in Korea (Emeset KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Emeset. The MFDS reviews the Emeset KDMF as part of the drug registration process and uses the information provided in the Emeset KDMF to evaluate the safety and efficacy of the drug.
After submitting a Emeset KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Emeset API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Emeset suppliers with KDMF on PharmaCompass.
A Emeset CEP of the European Pharmacopoeia monograph is often referred to as a Emeset Certificate of Suitability (COS). The purpose of a Emeset CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Emeset EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Emeset to their clients by showing that a Emeset CEP has been issued for it. The manufacturer submits a Emeset CEP (COS) as part of the market authorization procedure, and it takes on the role of a Emeset CEP holder for the record. Additionally, the data presented in the Emeset CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Emeset DMF.
A Emeset CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Emeset CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Emeset suppliers with CEP (COS) on PharmaCompass.
A Emeset written confirmation (Emeset WC) is an official document issued by a regulatory agency to a Emeset manufacturer, verifying that the manufacturing facility of a Emeset active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Emeset APIs or Emeset finished pharmaceutical products to another nation, regulatory agencies frequently require a Emeset WC (written confirmation) as part of the regulatory process.
click here to find a list of Emeset suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Emeset as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Emeset API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Emeset as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Emeset and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Emeset NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Emeset suppliers with NDC on PharmaCompass.
Emeset Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Emeset GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Emeset GMP manufacturer or Emeset GMP API supplier for your needs.
A Emeset CoA (Certificate of Analysis) is a formal document that attests to Emeset's compliance with Emeset specifications and serves as a tool for batch-level quality control.
Emeset CoA mostly includes findings from lab analyses of a specific batch. For each Emeset CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Emeset may be tested according to a variety of international standards, such as European Pharmacopoeia (Emeset EP), Emeset JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Emeset USP).